Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20210816052206N1Phase 3Completed
Phase 3, randomised, open-label trial of bupivacaine (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Shivering severity during and after cesarean section. Started Dec 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20210816052206N1.